Exclusive Summary

• Holds top-tier dual GMP certifications (US-FDA, UK-MHRA) with an approved US registration, enabling ultra-fast market access in emerging markets via reliance pathways.
• Features a high-barrier extended-release (ER) formulation across a complete range of strengths (2.5mg/5mg/10mg), ensuring 24-hour stable blood pressure control and facilitating precise dose titration.
• Combines international premium quality with China's supply chain cost efficiency, offering significant price advantages and higher downstream profit margins compared to the originator (Plendil) and Western generics.
• Ready for Distribution partnership models, allowing immediate commercialization through established overseas sales networks while minimizing partner time-to-market and development risks.